| What is RSS feed? | About Us |
 |
 Search Score: 4/10
Source: articles.moneycentral.msn.com --- 31 days ago
WASHINGTON (AP) - The pharmaceutical Industry's main trade group spent more than $5 million lobbying the federal government in the second quarter, according to a recent disclosure form. ... Source: news.yahoo.com --- 17 days ago
Bloomberg - Aug. 19 (Bloomberg) -- When Senator Charles Schumer, a New York Democrat, wanted to team up with a Republican on legislation making it easier to bring low-cost generic drugs to market, he found an eager partner: Arizona Senator John McCain. ... Source: www.businessweek.com --- 1 day ago
... Source: blogs.wsj.com --- 4 days ago
Shionogi is buying publicly traded Sciele Pharma in a deal worth $1.42 billion. The acquisition is one in a series of big U.S. acquisitions by Japanese Drug makers. ... Source: www.slate.com --- 10 days ago
Whether Barack Obama can remake American politics remains to be seen, but he does seem to have converted one significant constituency: pharmaceutical manufacturers. For decades, the Industry has given more to Republicans than to Democrats. This year, however, most Drug company money—at least to the presidential candidates—is going to Obama. [ more ... ] ... Source: www.prweb.com --- 29 days ago
The pharmaceutical Industry is reexamining its approach to quality control by focusing on new ways to detect microscopic contaminants in drugs. (PRWeb Aug 8, 2008) Read the full story at http://www.prweb.com/releases/pharmaceutical/microanalysis/prweb1191414.htm ... Source: www.kansas.com --- 19 days ago
Soon, those Drug-branded pens, clipboards and coffee mugs will be a thing of the past in physicians offices. The nation's largest pharmaceutical trade association now says its members can no longer hand out those trinkets and freebies, and it sharply curtailed when, where and how Drug companies can wine and dine physicians. The new code of conduct, which goes into effect Jan. 1, was designed to squelch, once and for all, any negative perceptions that doctors are influenced by or make prescribing choices as a result of gifts from Drug manufacturers. "It's ridiculous to think that a physician is going to be influenced by a cheap pen and a coffee mug," said Ken Johnson, a spokesman for Pharmaceutical Research and Manufacturers of America, which released its revised "Code of Interactions with Healthcare Professionals" last month. "But there was a perception that somehow these interactions were influencing prescribing decisions. In the final analysis, the perception became the reality, and we just decided it wasn't worth the fight any longer." ... Source: www.eitb24.com --- 23 hours ago
The higher proportion of deaths through five years was statistically significant only for the lowest dose of the Drug called Fablyn, said Food and Drug Administration reviewers. ... Source: www.thnt.com --- 13 days ago
One of several people at the Dover unemployment office last week from the pharmaceutical Industry, David Stern worked for a small company when layoffs hit a few months ago and a manager called him into an office. ... Source: www.fiercehealthcare.com --- 23 days ago
Concerned about the potential for undue Drug Industry influence, the American Psychiatric Association has appointed a work group to identify what Drug Industry money it's taken in, how the income is used and whether it should give up that money. The group's formation follows intense scrutiny of Drug Industry gifts and consulting arrangement with physicians of all types. Like other professional groups, the APA receives a fair amount of Industry dollars. Pharma revenue accounted for 28 percent, or $14 million, of the APA's 2007 budget, including journal advertising and grants for continuing medical education and fellowships. Among the income types receiving the toughest criticism are Drug-Industry-supported symposia. While the APA has said that it has set up "firewalls" to prevent Industry bias from diluting the content, critics say such safeguards have failed, given how easy it is to know what company is funding an event and what their views are. To learn more about this funding examination: - read this AMNews piece Related Articles: Harvard psychiatrists fail to reveal millions in pharma pay Psychiatrists getting the largest pharma gifts Senate to investigate Brown University psychiatrist ... Source: www.pharmaceuticalonline.com --- 15 days ago
Decision Resources, finds that opportunities abound to improve the market prospects for drugs and reverse the pharmaceutical Industry's decade-long productivity and performance slide. ... Source: www.ip-watch.org --- 29 days ago
By Claudia Jurberg for Intellectual Property Watch RIO DE JANEIRO - An investigation was conducted recently by the civil police in Sao Paulo State, Brazil, against multinational pharmaceutical companies, in which the prosecution affirmed that laboratories pay lawyers to get patients the right to obtain high-cost medicines through the Brazilian health ... ... Source: www.thehorse.com --- 19 days ago
Calls to action aren't new to The Jockey Club Round Table conference, but at this year's meeting Aug. 17 in Saratoga Springs, N.Y., there appeared to be a sense of urgency. Public perception and the threat of federal intervention have a way of moving... ... Source: www.injuryboard.com --- 11 days ago
Dr. Patrick Soon-Shiong, a billionaire pharmaceutical executive from American Pharmaceutical Partners (APP), is calling for the pharmaceutical Industry to reform how it polices its products. He argues these companies must take a larger role in insuring the safety of their products since the Food and Drug Administration (FDA) is so overwhelmed. Dr. Soon-Shiong is speaking so freely about this issue after he and his company, APP, stepped in during the heparin crisis, providing a large, safe supply of the Drug. Without this aid, many Americans may have suffered. Heparin is a blood thinner used daily in hospital surgeries and for kidney dialysis patients. This major Drug, one of the most used in America, fell into jeopardy last winter when it was found to be contaminated by an ingredient that was not accurately monitored by the FDA and the pharmaceutical companies themselves. It is believed that this contaminated Drug led to at least fifty-five deaths, though the FDA has only been able to find a link between the Drug and three deaths. http://abcnews.go.com/print?id=5441082 Leroy Hubey claims both his wife and son died after taking the contaminated heparin. Investigations into both of these deaths pointed to China, the place where the raw ingredients for heparin originate. The FDA concluded someone at the Chinese manufacturer spiked the crude heparin with a counterfeit similar looking Drug to increase profit. Unfortunately, heparin is ... Source: www.injuryboard.com --- 15 days ago
Las Vegas consumers of generic prescription medication andAmerican consumers have much to be worried about these days. We have discussed theinefficiencies of the FDA (given its current structure and underfunding) and the FDA's tendency to side with BigPharma in the current administration. Now, we must all be concerned with a possible merger on thehorizon. Who? Teva Pharmaceuticals and Barr. For more on this possible deal clickthese links below: Deal Information http://www.sec.gov/Archives/edgar/data/818686/000089914008001470/t4306405b.txt Press release: http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20080718005161&newsLang=en Conference Calls: 7/21/2008 Teva Barr Luncheon http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=73925&eventID=1905366 7/18/2008 Teva to Acquire Barr: http://www.earnings.com/conferencecallhost.asp?event=1904570&client=cb If this deal goes through,two of the largest generic companies will merge and they will control a largepart of the generic prescription Drug market. This should be a concern for usall. For instance, both of thecompanies manufacture metoclopramide. We know the problems with that Drug, we should ask ourselves are thereother problematic drugs too? Howwill this merger affect the American consumer? Will they put patient safety first? Originally posted at InjuryBoard by Peter Wetherall ... Source: www.fwicki.com --- 34 days ago
Wednesday was a very important day, or one could even call it a historic day, for the tobacco Industry: a law, giving the US Food and Drug Administration authority over regulating cigarettes and any other type of tobacco products, cleared the US ... ... Source: www.topix.com --- 8 days ago
Which candidate would be the best for Drug Industry?; AstraZeneca is maker of popular Crestor, Prilosec, Nexium drugs; Rport: Uninsured Americans pay $30 Billion per year on healthcare; McCain, Obama debate ... ... Source: www.amednews.com --- 25 days ago
Concerned about conflicts of interest, the specialty society is pondering a move away from pharmaceutical funding over a five-year period. ... Source: www.nanovip.com --- 4 days ago
Short description Neowater provides a new solubilization service, which has significant value-added in Drug-delivery applications due to increased stability of compounds solvated. Article body Do-Coop Technologies Ltd. is a private company based in Israel. Its primal goal is to develop and commercialize novel water-based materials using Nanotechnology for the biotechnology, pharmaceutical and chemical industries. Do-Coop has developed a patented Nanotechnology to modify the properties of water, using nanoparticles, enabling the first ever introduction of water-based biomaterials. Do-Coop has recently started commercialization of its first line of products, branded as Neowater, targeting the molecular diagnostics and research market within the Life Sciences Industry. The company is now offering a new solubilization service for Pharma and Biotech companies, in order to enhance bioavailability and solubility of existing and new drugs. A new solubilization service, provided by Neowater, is a water-based nanotechnology, which has significant value-added in Drug delivery applications due to increased stability of compounds solvated by Neowater. Breakthrough nanotechnology, developed in Israel, modifies the physical properties of water molecules: each nanoparticle organizes the water molecules surrounding it. Customers of Neowater receive a sterile, sealed vial with a maximum effective concentration, with Neowater replacing its organic solvent ... Source: www.newsback.com --- 25 days ago
Forum: Columns Posted By: HenryMiller Post Time: 08-12-2008 at 10:08 AM ... Find more results for Drug Industry on RSSMicro.com |
Copyright © 2008 RSSMicro.com
![This Week We Were Rage-O-Holics And Our Drug Of Choice Was Palin [The Week That Was]](http://jezebel.com/assets/images/jezebel/2008/09/sadbear111607.jpg)
